Citigroup

Citigroup has identified a long/short pair trade in the offshore drilling sector as it previews third quarter results.  A pair trade is a strategy of taking opposing positions in two highly correlated instruments in a bid to mitigate risk. Citi upgraded shares of Transocean LTD (NYSE: RIG)...

Despite the 280 percent year-to-date gains in Puma Biotechnology Inc (NASDAQ: PBYI) shares, Citigroup is projecting shares could go higher.  Citi maintained its Buy on Puma Biotechnology and raised its price target from $114 to $156. At the time of writing, shares of Puma Biotechnology were...

Citigroup downgraded shares of GrubHub Inc (NYSE: GRUB), as it believes the recent run up in shares is now reflecting the near-term outlook. The firm noted that GrubHub shares have gained 44 percent in the year-to-date period and has added 12 percent or $6 per share since it announced the...

Pre-open movers U.S. stock futures traded flat in early pre-market trade. The Challenger job-cut report for September is schedule for release at 7:30 a.m. ET. Data on international trade for August and initial jobless claims for the latest week will be released at 8:30 a.m. ET. Data on factory...

It’s like that movie scene when the alpha rolls up in his polished Corvette, revs his engine with a wink and the ladies swoon. Except in this scenario, ruggedly handsome General Motors Company (NYSE: GM) is winning the Street without even touching the gas. Ahead of a Monday announcement...

Pre-open movers U.S. stock futures traded lower in early pre-market trade. Data on Gross Domestic Product, initial jobless claims and international trade in goods will be released at 8:30 a.m. ET. Kansas City Federal Reserve Bank President Esther George is set to speak in Kansas City at 9:45 a.m....

Citigroup in a note released Monday, delved into the roadmap for Mirati Therapeutics, Inc. (NASDAQ: MRTX). The firm feels the response for its targeted agent sitravatinib in CBL-mutated non-small cell lung cancer patients puts the company back on targeted therapy map. CBL is a ubiquitin E3 ligase...

Pre-open movers U.S. stock futures traded lower in early pre-market trade. Federal Reserve Governor Lael Brainard is to speak in New York City at 7:30 a.m. ET. Data on factory orders for July will be released at 10:00 a.m. ET. Minneapolis Federal Reserve Bank President Neel Kashkari will speak in...

Pre-open movers U.S. stock futures traded higher in early pre-market trade. The ADP national employment report for August will be released at 8:15 a.m. ET, while the Gross Domestic Product report for the second quarter is schedule for release at 8:30 a.m. ET. Federal Reserve Governor Jerome Powell...

Following its meeting with the management of Energizer Holdings Inc (NYSE: ENR), Citigroup's Wendy Nelson said the company's shares now offer a terrific buying opportunity. Nelson noted that Energizer shares have fallen about 30 percent over the last four months, primarily due to the...

This weekend's Barron's offers a look at a financial giant that has laid out some ambitious goals. Other featured articles discuss an industrial giant with a new chief executive and a specialty retailer that is turning things around. The prospects for a pair of social media giants...

Facebook Inc (NASDAQ: FB) shares jumped more than 5 percent on Thursday after the company’s second-quarter earnings report blew expectations out of the water. A number of Wall Street analyst weighed in on Facebook following the report. Here’s a rundown of what they had to say. Voices...

Earnings season may be stealing the headlines this week, but M&A chatter is still fervent on the Street. Investors are keeping a close eye on the AT&T Inc. (NYSE: T)—Time Warner Inc (NYSE: TWX) merger and the fates of Sprint Corp (NYSE: S) and T-Mobile US Inc (NASDAQ: TMUS). But...

Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) reported a strong second-quarter earnings beat Monday, despite taking a $2.7 billion hit from the European Commission’s fine last month, but shares traded down about 3 percent after hours. The dip was also in part due to an increase in the company...

Following strong Phase I and II data on Tuesday from three different triple combo regimens for cystic fibrosis, shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) rocketed 30 percent Wednesday to $162.07. The stock’s climb to a new all-time high was assisted by a string of analyst...